CDSCO cancels FatX registration over product claims
In short
CDSCO has cancelled FatX’s registration over claims about one of its products. The order says the company was marketing it as something that could dissolve fat cells and make them smaller.
This matters because the regulator treated those claims like drug claims. The reporting does not say what FatX will do next or whether the product can still be sold.
What the reporting says
CDSCO cancelled FatX’s registration over misleading claims about a product, according to a publisher summary. The order says the company was marketing it as a treatment for dissolving fat cells and reducing their size, which the regulator treated as drug claims. The immediate consequence is regulatory action against the product, while the reporting does not state the company’s response or whether sales were stopped.
Why it matters
CDSCO cancelled FatX’s registration after saying the company was marketing a product with claims that it could dissolve fat cells and reduce their size. The publisher summary says the regulator viewed those claims as drug claims. The reporting does not state when the order was issued, whether the product was pulled from the market, or what FatX’s response was.